NHS National Framework for Transition Products (Nintedanib and Dalbavancin)
Project title: NHS National Framework for Transition Products (Nintedanib and Dalbavancin) commencing 1st May 2026 Offer reference number: CM/TNS/25/5736 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months. Potential periods of call-offs under the framework agreement: CM/TNS/25/5736 Nintedanib and Dalbavancin Lot 1 DLN/DNW: 01/05/2026 to 30/09/2027 (17 months) Lot 2 DLS/DNE: 01/05/2026 to 31/05/2027 (13 months) Lo...
Buyer
NHS England
Value
Not provided
Published
11 May 2026
Closes
28 Jan 2026
Procurement details
Source
Atamis NHS Projects
Region
London
Procurement method
Not provided
Category
Not provided
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
No CPV codes are available for this public record.
Lots
Lot default NHS National Framework for Transition Products (Nintedanib and Dalbavancin)
Value not provided
NHS National Framework for Transition Products (Nintedanib and Dalbavancin) from NHS England (unknown value) with deadline 28 Jan 2026.
Delivery: United Kingdom
Documents
Unlock document linkAtamis tender page
Not provided
Notice
Contains public sector information licensed under the Open Government Licence v3.0.